Novel purpose of OCT4B protein isomer
A technology of OCT4B-265, 1.OCT4B-265, which is applied in the new application field of OCT4B protein isomers, and can solve problems such as unclear biological functions
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0035] Example 1. Expression of OCT4B-265 protein and its subcellular localization in different cell lines under cell stress conditions
[0036] OCT4B-265 protein is a protein isoform with 265 amino acids translated from OCT4B mRNA with ATG as the start codon. Its amino acid sequence is sequence 1 in the sequence listing, and its full-length cDNA sequence is sequence listing Sequence 2, the entire open reading frame has a total length of 798 bases.
[0037] 1. Expression of OCT4B-265 protein in different cell lines under cell stress conditions
[0038] NTERA-2、MCF-7、293T、PA-1、HepG2、RT-4细胞细胞系购自北京协和细胞中心;资源编号依次分别为3111C0001CCC000019、3111C0001CCC000013、3111C0001CCC000091、3111C0001CCC000021、3111C0001CCC000035、3131C0001001200015;
[0039] The human embryonic stem cell line (hES) H9 was purchased from the stem cell technology platform of the Institute of Biochemical Cells, Shanghai Academy of Biological Sciences, Chinese Academy of Sciences.
[0040] The medium used for the above-me...
Embodiment 2
[0079] Example 2, OCT4B-265 protein promotes apoptosis
[0080] 1. Adenovirus transfection
[0081] The adenovirus containing the gene encoding the OCT4B-265 (m) protein was purchased from Beijing Nuosai Gene Company (the nucleotide sequence of the gene encoding the OCT4B-265 (m) protein is sequence 4 in the sequence listing) and the negative control virus; the virus The titers were all 1×10 10 pfu / ml.
[0082] According to the standard procedure of the manufacturer, the adenovirus containing the gene encoding OCT4B-265 (m) protein and the negative control virus (MOI=35) diluted to different titers (MOI=70 and MOI=35) were transfected into MCF-7 cells, Transgenic cells V-265 transfected with different titers (MOI=70 and MOI=35) and control V-null cells were obtained respectively.
[0083] Transgenic cells V-265 transfected with different titers (MOI=70 and MOI=35) and control V-null cells at 36 hours of transfection above were treated with mitomycin C (GR-311, Enzo Life Sci...
Embodiment 3
[0090] Example 3. Genes related to OCT4B-265 protein expression
[0091] 1. The effect of small interfering RNA transfection on the apoptosis rate of MCF-7 cells overexpressing OCT4B-265 protein
[0092] The nucleotide of the human p53 tumor suppressor gene is sequence 7 in the sequence list.
[0093] Human p53 small interfering RNA was purchased from Shanghai Gemma Company, and its forward sequence was: 5'CUACUUCCUGAAAACACGdTdT3' (sequence 5); the reverse sequence was: 5'CGUUGUUUUCAGGAAGUAGdTdT3' (sequence 6).
[0094] Follow the standard steps in the instructions, using Lipofectamine TM RNAiMAX (Invitrogen) transfection reagent, human p53 small interfering RNA was transfected into the transgenic cell V-265 obtained in 1 of Example 2 (identified as positive, MOI=35), and the transgenic cell p53i-V- 265 (MCF-7);
[0095] Control p53i-V-null cells (MCF-7): Human p53 small interfering RNA was transfected into the control group V-null cells obtained in 1 of Example 2 to obtain...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com